Average Co-Inventor Count = 4.69
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Reddy US Therapeutics, Inc. (17 from 19 patents)
2. Atherogenics, Inc. (4 from 25 patents)
3. Other (2 from 832,680 patents)
4. Kareus Therapeutics, Sa (2 from 3 patents)
5. Reddy U5 Therapeutics, Inc. (1 from 1 patent)
26 patents:
1. 9464053 - Compositions for reducing Aβ 42 production and their use in treating alzheimer's disease (AD)
2. 8846721 - Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD)
3. 8541435 - Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)
4. 8008328 - Methods for the treatment of diabetes-associated dyslipdemia
5. 7335656 - Medical devices employing triazine compounds and compositions thereof
6. 7335770 - Triazine compounds and their analogs, compositions, and methods
7. 7332490 - Methods and compositions of novel triazine compounds
8. 7332488 - Methods and compositions of novel triazine compounds
9. 7332489 - Methods and compositions of novel triazine compounds
10. 7273712 - Methods and compositions for detecting compounds that modulate inflammatory responses
11. 7268134 - Medical devices employing triazine compounds and compositions thereof
12. 7265114 - Methods and compositions of novel triazine compounds
13. 7238692 - Medical devices employing triazine compounds and compositions thereof
14. 7183317 - Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
15. 7173032 - Methods and compositions of novel triazine compounds